SCHEMBL18309801

SCHEMBL18309801

Cc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 5/20 0.81
ADORA3 P0DMS8 5/20 0.81
SLC6A2 P23975 5/20 0.81
SLC6A4 P31645 5/20 0.81
SLC6A3 Q01959 5/20 0.81
KCNH2 Q12809 5/20 0.81
NR1I2 O75469 4/20 0.81
NR3C1 P04150 4/20 0.81
CYP17A1 P05093 4/20 0.81
ADRB1 P08588 4/20 0.81
DRD2 P14416 4/20 0.81
OPRK1 P41145 4/20 0.81
DRD3 P35462 4/20 0.81
CHRM3 P20309 3/20 0.81
HTR2A P28223 3/20 0.81
OPRD1 P41143 3/20 0.81
PDE4D Q08499 3/20 0.81
TBXA2R P21731 3/20 0.81
ADRA2C P18825 2/20 0.81
ADRA1A P35348 2/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tioconazole SCHEMBL3682098 0.90 PGR (1.00) PGRADORA3SLC6A2SLC6A4SLC6A3
Tioconazole SCHEMBL29882046 0.90 PGR (1.00) PGRADORA3SLC6A2SLC6A4SLC6A3
Tioconazole SCHEMBL29881791 0.90 PGR (1.00) PGRADORA3SLC6A2SLC6A4SLC6A3
Tioconazole SCHEMBL29408808 0.90 PGR (1.00) PGRADORA3SLC6A2SLC6A4SLC6A3
Tioconazole SCHEMBL3682100 0.90 PGR (1.00) PGRADORA3SLC6A2SLC6A4SLC6A3
Tioconazole SCHEMBL41354 0.90 PGR (1.00) PGRADORA3SLC6A2SLC6A4SLC6A3
Tioconazole SCHEMBL41355 0.90 PGR (1.00) PGRADORA3SLC6A2SLC6A4SLC6A3
Tioconazole SCHEMBL7165888 0.89 PGR (0.98) PGRADORA3SLC6A2SLC6A4SLC6A3
Tioconazole SCHEMBL3722115 0.89 PGR (0.98) PGRADORA3SLC6A2SLC6A4SLC6A3
Tioconazole SCHEMBL7165886 0.89 PGR (0.98) PGRADORA3SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160361298-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER GLOBAVIR BIOSCIENCES, INC. 2016-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160361298-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER IDO2, IDO1, TDO2 PGR 1989/4885ADORA3 1501/4885SLC6A2 1349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.